Vanguard Group Inc Anixa Biosciences Inc Call Options Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ANIX
# of Institutions
64Shares Held
5.7MCall Options Held
7.1KPut Options Held
26.7K-
Laird Norton Trust Company, LLC622KShares$1.66 Million0.21% of portfolio
-
D.A. Davidson & Co.614KShares$1.63 Million0.01% of portfolio
-
Ubs Group Ag534KShares$1.42 Million0.0% of portfolio
-
Mission Wealth Management, LP470KShares$1.25 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA329KShares$876,1420.0% of portfolio
About Anixa Biosciences Inc
- Ticker ANIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,661,700
- Market Cap $81.6M
- Description
- Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...